Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 395

1.

Vaccines Through Centuries: Major Cornerstones of Global Health.

Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A.

Front Public Health. 2015 Nov 26;3:269. doi: 10.3389/fpubh.2015.00269. eCollection 2015. Review.

2.

A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia.

Wang PC, Mwango A, Moberley S, Brockman BJ, Connor AL, Kalesha-Masumbu P, Mutembo S, Bweupe M, Chanda-Kapata P, Biemba G, Hamer DH, Chibuye B, McCarthy E.

PLoS One. 2015 Oct 29;10(10):e0141455. doi: 10.1371/journal.pone.0141455. eCollection 2015.

3.

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers.

MacDougall DM, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

BMJ Open. 2015 Sep 29;5(9):e009062. doi: 10.1136/bmjopen-2015-009062.

4.

Adsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses.

Bortolatto J, Mirotti L, Rodriguez D, Gomes E, Russo M.

J Immunol Res. 2015;2015:280238. doi: 10.1155/2015/280238. Epub 2015 Aug 25.

5.

Risk factors for delay in age-appropriate vaccinations among Gambian children.

Odutola A, Afolabi MO, Ogundare EO, Lowe-Jallow YN, Worwui A, Okebe J, Ota MO.

BMC Health Serv Res. 2015 Aug 28;15:346. doi: 10.1186/s12913-015-1015-9.

6.

New Insight into Filamentous Hemagglutinin Secretion Reveals a Role for Full-Length FhaB in Bordetella Virulence.

Melvin JA, Scheller EV, Noël CR, Cotter PA.

MBio. 2015 Aug 18;6(4). pii: e01189-15. doi: 10.1128/mBio.01189-15.

7.

Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan.

Schweitzer A, Krause G, Pessler F, Akmatov MK.

BMC Public Health. 2015 Aug 19;15:798. doi: 10.1186/s12889-015-2091-9.

8.
9.

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012.

Levi M, Donzellini M, Varone O, Sala A, Bechini A, Boccalini S, Bonanni P.

J Prev Med Hyg. 2014 Dec;55(4):145-51.

10.

Pertussis Prevalence in Korean Adolescents and Adults with Persistent Cough.

Lee SY, Han SB, Kang JH, Kim JS.

J Korean Med Sci. 2015 Jul;30(7):988-90. doi: 10.3346/jkms.2015.30.7.988. Epub 2015 Jun 10.

11.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

MacDougall D, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Hum Vaccin Immunother. 2015;11(9):2167-79. doi: 10.1080/21645515.2015.1046662. Epub 2015 Jun 19.

12.

Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trial.

Pavia-Ruz N, Abarca K, Lepetic A, Cervantes-Apolinar MY, Hardt K, Jayadeva G, Kuriyakose S, Han HH, de la O M.

Hum Vaccin Immunother. 2015;11(7):1770-4. doi: 10.1080/21645515.2015.1041697.

13.

Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age.

Ko HS, Jo YS, Kim YH, Park YG, Wie JH, Cheon J, Moon HB, Lee Y, Shin JC.

Yonsei Med J. 2015 Jul;56(4):1071-8. doi: 10.3349/ymj.2015.56.4.1071.

14.

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine.

Dalvi S, Kulkarni PS, Phadke MA, More SS, Lalwani SK, Jain D, Manglani M, Garg BS, Doibale MK, Deshmukh CT; SIIL DTwP + HepB Hib Author Group.

Hum Vaccin Immunother. 2015;11(4):901-7. doi: 10.1080/21645515.2015.1010953. Erratum in: Hum Vaccin Immunother. 2015;11(7):1879.

15.

Prevention of pertussis through adult vaccination.

Suryadevara M, Domachowske JB.

Hum Vaccin Immunother. 2015;11(7):1744-7. doi: 10.1080/21645515.2015.1038442. Review.

16.

A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM.

PLoS Comput Biol. 2015 Apr 23;11(4):e1004138. doi: 10.1371/journal.pcbi.1004138. eCollection 2015 Apr.

17.
18.

Gender-specific mortality in DTP-IPV- and MMR±MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study.

Schurink-van't Klooster TM, Knol MJ, de Melker HE, van der Sande MA.

BMC Infect Dis. 2015 Mar 24;15:148. doi: 10.1186/s12879-015-0898-8.

19.

Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases.

Lin CY, Lin SJ, Yang YC, Wang DY, Cheng HF, Yeh MK.

Hum Vaccin Immunother. 2015;11(3):650-6. doi: 10.1080/21645515.2015.1009345. Review.

20.

Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.

Iwata S, Kawamura N, Kuroki H, Tokoeda Y, Miyazu M, Iwai A, Oishi T, Sato T, Suyama A, François N, Shafi F, Ruiz-Guiñazú J, Borys D.

Hum Vaccin Immunother. 2015;11(4):826-37. doi: 10.1080/21645515.2015.1012019.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk